Please login to the form below
Access to Medicines Index
This page shows the latest Access to Medicines Index news and features for those working in and with pharma, biotech and healthcare.
GSK tops Access to Medicines Index for fifth time running
The company topped the Access to Medicines Index for the fifth consecutive time after the biannual good practice report found it “the most access-oriented company” of the top 20 pharma ... The Access to Medicines Index 2016. View the Access to
Latest news
-
GSK unveils access plan for low-income countries
The company's chief executive Sir Andrew Witty - who will step down next year - announced the measure just ahead of the UN High Level Panel on Access to Medicines yesterday. ... GSK already has a good track record on medicines access, ranking at number
-
Novartis to make 15 drugs available at $1 a month
Novartis has launched an access programme aimed at low-and middle-income countries that will make 15 of its medicines for chronic diseases available at a knockdown price. ... Novartis was ranked fourth in the 2014 Access to Medicines Index funded by the
-
GSK tops pharma access to medicines table
The biannual Access To Medicines Index (ATMI) - which is funded by the Bill &Melinda Gates Foundation and the UK and Dutch governments - puts GlaxoSmithKline at the top of its rankings in ... The Access to Medicines Index 2014. "In recent years,
-
EU pharma heading efforts to get drugs to the poor
The Access to Medicines Index was launched on June 16 and shows that only one US manufacturer, Merck &Co, which came third, has made it into the top seven. ... Leereveld said that the most striking fact is that the index, set up by the Access to Medicine
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
